The UCSF Helen Diller Family Comprehensive Cancer Center has thrived under Director Frank McCormick, who has served as an outstanding research mentor and collaborator with the Thoracic Oncology Lab.
The Lab has integrated itself well into the activities of the cancer center and established relationships with numerous other labs. The Thoracic Oncology Research Group (TORG), an interdisciplinary collaboration of physician-scientists and basic scientists, focuses on discovering treatments and cures for lung cancer, mesothelioma and other malignancies.
TORG serves as a catalyst for ideas and discussion. It alllows for collaboration through RFAs, program project grants and one day through a lung SPORE. The membership includes a distinguished group of investigators, most independently funded through NIH and private funding.
The Thoracic Oncology Lab also supports the renewed translational research focus of the cancer center. The lab's work in diagnostics and therapeutic development dovetail with the goals of the recently appointed Director of Investigational Therapeutics at the UCSF Helen Diller Family Comprehensive Cancer, Dr. Eric Small. His primary goal, the development of robust, innovative clinical trials across all malignancies, will be advanced by the Thoracic Oncology Program's bench-to-bedside enterprise, the translational research lab being a core component.
View Complete List of Thoracic Oncology Collaborators


plustag.jpg)
